Dianeal + Dianeal, Extraneal, Nutrineal
Phase 3Completed 0 watching 0 views this week📈 Rising
74
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
End Stage Renal Disease (ESRD)
Conditions
End Stage Renal Disease (ESRD), Diabetes, CAPD
Trial Timeline
Oct 1, 2010 → Jul 1, 2011
NCT ID
NCT01219959About Dianeal + Dianeal, Extraneal, Nutrineal
Dianeal + Dianeal, Extraneal, Nutrineal is a phase 3 stage product being developed by Baxter for End Stage Renal Disease (ESRD). The current trial status is completed. This product is registered under clinical trial identifier NCT01219959. Target conditions include End Stage Renal Disease (ESRD), Diabetes, CAPD.
Hype Score Breakdown
Clinical
27
Activity
18
Company
7
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01219959 | Phase 3 | Completed |
Competing Products
20 competing products in End Stage Renal Disease (ESRD)